Nanocrine
Frederick, US · 2 known investors
Nanocrine develops a plasmonic microscopy platform, originally based on technology from the US Navy, that lets researchers detect and map molecules secreted by individual cells with spatial and temporal precision. It serves life science researchers and clinicians studying disease biology in contexts such as the tumor microenvironment, wound healing, and stem cell biology.
Founders & leadership
ST
Steve TurnerCo-Founder, Chairman
JB
Jim BaileyCo-founder; Director; Business Advisor
PJ
Patrick J. CalhounPresident & Chief Science Officer
KW
Ken WolfChief Communications Director
Investors · 2
Competitors · 1
by search overlapCompanies competing with Nanocrine for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2020 | $248.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Nanocrine do?
- Nanocrine develops a plasmonic microscopy platform, originally based on technology from the US Navy, that lets researchers detect and map molecules secreted by individual cells with spatial and temporal precision. It serves life science researchers and clinicians studying disease biology in contexts such as the tumor microenvironment, wound healing, and stem cell biology.
- Who founded Nanocrine?
- Nanocrine was founded by Steve Turner, Jim Bailey.
- Who are Nanocrine's investors?
- Nanocrine's investors include Maryland TEDCO, TEDCO.
- Where is Nanocrine headquartered?
- Nanocrine is headquartered in Frederick, US.